[144] LegalZoom.com, Inc. SEC Filing
Form 144 filed for LegalZoom.com, Inc. (LZ) reports a proposed sale of 27,319 common shares through Fidelity Brokerage Services on 08/25/2025 on NASDAQ, with an aggregate market value of $302,511.20. The filing shows these shares were acquired by restricted stock vesting from the issuer on 11/15/2023 (8,934 shares) and 02/15/2024 (18,385 shares) as compensation.
The document also discloses recent sales by the same person: 15,000 shares sold on 08/18/2025 for gross proceeds of $162,116.35 and 18,136 shares sold on 08/22/2025 for $200,103.39, totaling 33,136 shares sold in the past three months. The filer attests no undisclosed material adverse information and includes standard Rule 10b5-1 language.
- Compliance disclosure: Filing includes acquisition details, sale dates, broker, and gross proceeds for recent sales, meeting Rule 144 disclosure requirements
- Source of shares disclosed: Shares were acquired via restricted stock vesting as compensation on 11/15/2023 and 02/15/2024
- Insider selling activity: Recent sales total 33,136 shares in the past three months, and a further 27,319 shares are proposed to be sold, which may be viewed negatively by some investors
- Missing trading-plan detail: The filing does not specify a Rule 10b5-1 plan adoption date or provide details of any written trading plan
Insights
TL;DR Insider reported planned sale of 27,319 vested shares and completed recent sales totaling 33,136 shares.
The filing documents routine disposition of vested restricted stock acquired as compensation in 2023 and 2024. Sales were executed through a registered broker on NASDAQ with disclosed gross proceeds for the past transactions. For investors, insider selling can reflect liquidity needs rather than a change in company fundamentals; the amounts represent a small fraction of the issuer's reported outstanding shares (180,249,374).
TL;DR Disclosure meets Rule 144 requirements and includes attestations regarding material non-public information.
The filing includes acquisition dates, nature of acquisition (restricted stock vesting), and payment nature (compensation), plus recent trades and planned sale date. The presence of Rule 10b5-1 language and signature attestation aligns with compliance norms. No indication of plan adoption date or trading plan details is provided in the filing.